We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jean Hoffman-Censits

Jean Hoffman-Censits MD

Assistant Professor, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Departments of Medical Oncology and Urology, Johns Hopkins Greenberg Bladder Cancer Institute. Baltimore, MD

Dr. Jean Hoffman-Censits is an Assistant Professor in the Departments of Medical Oncology and Urology at the The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Her research focus is on the development of novel therapeutics and treatment strategies for locally advanced and metastatic urothelial cancers. Her clinical interests include rare populations such as patients with upper tract urothelial cancer, bladder and upper tract tumors with variant histology, and women with these cancers. Dr. Hoffman-Censits was the medical oncology lead investigator of EA8141, the first prospective multicenter trial of neoadjuvant chemotherapy for UTUC. She joined the Johns Hopkins Greenberg Bladder Cancer Institute in 2018.

Disclosures

Disclosures:

Advisory Board: Seattle Genetics

Research Support: Genentech, Foundation Medicine

Consulting: Astra Zeneca